International Clinical Trial: A pilot study of safety and clinical efficacy of oral immunotherapy with lyophilized shrimp extract (LSE) in shrimp allergic patients

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (TCTR20250808001) titled 'A pilot study of safety and clinical efficacy of oral immunotherapy with lyophilized shrimp extract (LSE) in shrimp allergic patients' on Aug. 8.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Phramongkutklao College of Medicine, Royal Thai Army Medical Department.

Condition: Safety and efficacy of oral immunotherapy with lyophilized shrimp extract in patients with shrimp allergy. oral immunotherapy, lyophilized shrimp extract, shrimp allergy oral immunotherapy, lyophilized shrimp extract, shrimp allergy

Intervention: Oral immunotherapy (OIT) with lyophilized shrimp extract (LSE) for ...